当前位置: X-MOL 学术Addict. Res. Theory › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Media coverage about medical benefits of MDMA and ketamine affects perceived likelihood of engaging in recreational use
Addiction Research & Theory ( IF 3.007 ) Pub Date : 2021-06-24 , DOI: 10.1080/16066359.2021.1940972
Joseph J Palamar 1 , Austin Le 1, 2
Affiliation  

Abstract

Background

Research on the efficacy of ketamine in treating depression and 3,4-methylenedioxymethamphetamine (MDMA) in treating post-traumatic stress disorder have been widely covered by the media. Given recent widespread coverage of the efficacy of these drugs, it is important to determine whether such coverage influences prevalence of recreational use. While longitudinal studies would be most ideal for assessing this, to acquire preliminary data, we tested survey items assessing this potential phenomenon in a population known for high prevalence of use of these drugs.

Method

Adults entering randomly selected nightclubs in New York City (n = 209) were surveyed about drug use. Questions were included to assess their perceived likelihood of recent media coverage about medical benefits associated with use of ketamine and MDMA affecting their own use.

Results

Two-thirds (66.8%) of participants had ever used ecstasy/MDMA and 22.6% had ever used ketamine. The plurality of participants reported that media coverage about ketamine (46.1%) and MDMA (39.9%) did not affect their likelihood of using. 10.1% and 21.0% of participants reported increased likelihood of using ketamine and MDMA, respectively. 52.3% of those reporting past-month ketamine use and 6.1% of those reporting no lifetime use reported being more likely to use in response to media coverage about ketamine. 28.6% of those reporting past-month ecstasy use and 5.5% of those reporting no lifetime use reported being more likely to use in response to media coverage about MDMA.

Discussion

Media coverage about the medical benefits of ketamine and MDMA might influence specific subsets of people to use.



中文翻译:

媒体对 MDMA 和氯胺酮的医疗益处的报道会影响人们参与娱乐用途的可能性

摘要

背景

氯胺酮治疗抑郁症和3,4-亚甲二氧基甲基苯丙胺(MDMA)治疗创伤后应激障碍的疗效研究已被媒体广泛报道。鉴于最近对这些药物功效的广泛报道,确定这种报道是否影响娱乐性使用的流行程度非常重要。虽然纵向研究对于评估这一点是最理想的,但为了获得初步数据,我们测试了一些调查项目,以评估这些药物使用率高的人群中的这种潜在现象。

方法

对进入纽约市随机选择的夜总会的成年人(n  = 209)进行了有关吸毒情况的调查。其中包括一些问题,以评估最近媒体报道与使用氯胺酮和摇头丸相关的医疗益处影响其自身使用的可能性。

结果

三分之二 (66.8%) 的参与者曾经使用过摇头丸/摇头丸,22.6% 的参与者曾经使用过氯胺酮。多数参与者表示,媒体对氯胺酮(46.1%)和摇头丸(39.9%)的报道并没有影响他们使用的可能性。10.1% 和 21.0% 的参与者分别表示使用氯胺酮和 MDMA 的可能性增加。在报告过去一个月使用过氯胺酮的人中,有 52.3% 的人以及在终生没有使用过氯胺酮的人中,有 6.1% 的人表示更有可能因媒体有关氯胺酮的报道而使用氯胺酮。在报告过去一个月使用过摇头丸的人中,有 28.6% 的人以及在终生没有使用过摇头丸的人中,有 5.5% 的人表示更有可能因媒体报道有关摇头丸而使用摇头丸。

讨论

媒体对氯胺酮和 MDMA 医疗益处的报道可能会影响特定人群的使用。

更新日期:2021-06-24
down
wechat
bug